| 2.72 0.05 (1.87%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.65  |
1-year : | 4.23 |
| Resists | First : | 3.12 |
Second : | 3.63 |
| Pivot price | 2.74 |
|||
| Supports | First : | 2.3 | Second : | 1.92 |
| MAs | MA(5) : | 2.66 |
MA(20) : | 2.82 |
| MA(100) : | 2.8 |
MA(250) : | 2.62 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 44.8 |
D(3) : | 40.7 |
| RSI | RSI(14): 46.1 |
|||
| 52-week | High : | 4.15 | Low : | 1.84 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ FORA ] has closed above bottom band by 45.0%. Bollinger Bands are 19.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.72 - 2.74 | 2.74 - 2.75 |
| Low: | 2.58 - 2.59 | 2.59 - 2.61 |
| Close: | 2.7 - 2.72 | 2.72 - 2.74 |
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Sun, 14 Apr 2024
Forian Inc. Announces the Passing of Director Martin J. Wygod - GlobeNewswire
Fri, 05 Apr 2024
Forian (NASDAQ:FORA) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Simply Wall St
Wed, 03 Apr 2024
Unpleasant Surprises Could Be In Store For Forian Inc.'s (NASDAQ:FORA) Shares - Simply Wall St
Mon, 01 Apr 2024
Forian Inc. (NASDAQ:FORA) Q4 2023 Earnings Call Transcript - Yahoo Finance
Thu, 28 Mar 2024
Forian Inc (FORA) Outperforms Analyst Revenue Estimates and Achieves Positive Adjusted EBITDA - Yahoo Finance
Thu, 28 Mar 2024
Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 31 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 49.3 (%) |
| Held by Institutions | 13.4 (%) |
| Shares Short | 166 (K) |
| Shares Short P.Month | 173 (K) |
| EPS | 0.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.85 |
| Profit Margin | 54.2 % |
| Operating Margin | -17 % |
| Return on Assets (ttm) | -6 % |
| Return on Equity (ttm) | 8.9 % |
| Qtrly Rev. Growth | 8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.65 |
| EBITDA (p.s.) | -0.16 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | 54.4 |
| PEG Ratio | 0 |
| Price to Book value | 3.2 |
| Price to Sales | 4.13 |
| Price to Cash Flow | 116.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|